• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KCNA1 活性完全丧失导致新生儿癫痫性脑病和运动障碍。

Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.

机构信息

Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Catalunya, Spain.

Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain.

出版信息

J Med Genet. 2020 Feb;57(2):132-137. doi: 10.1136/jmedgenet-2019-106373. Epub 2019 Oct 5.

DOI:10.1136/jmedgenet-2019-106373
PMID:31586945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7029237/
Abstract

BACKGROUND

Since 1994, over 50 families affected by the episodic ataxia type 1 disease spectrum have been described with mutations in , encoding the voltage-gated K channel subunit Kv1.1. All of these mutations are either transmitted in an autosomal-dominant mode or found as events.

METHODS

A patient presenting with a severe combination of dyskinesia and neonatal epileptic encephalopathy was sequenced by whole-exome sequencing (WES). A candidate variant was tested using cellular assays and patch-clamp recordings.

RESULTS

WES revealed a homozygous variant (p.Val368Leu) in , involving a conserved residue in the pore domain, close to the selectivity signature sequence for K ions (TVGYG). Functional analysis showed that mutant protein alone failed to produce functional channels in homozygous state, while coexpression with wild-type produced no effects on K currents, similar to wild-type protein alone. Treatment with oxcarbazepine, a sodium channel blocker, proved effective in controlling seizures.

CONCLUSION

This newly identified variant is the first to be reported to act in a recessive mode of inheritance in . These findings serve as a cautionary tale for the diagnosis of channelopathies, in which an unreported phenotypic presentation or mode of inheritance for the variant of interest can hinder the identification of causative variants and adequate treatment choice.

摘要

背景

自 1994 年以来,已有超过 50 个受发作性共济失调 1 型疾病谱影响的家族被描述,这些家族的基因突变都位于 基因上,该基因编码电压门控钾通道亚单位 Kv1.1。所有这些突变要么以常染色体显性模式遗传,要么以纯合缺失的形式出现。

方法

通过全外显子组测序(WES)对一名表现出严重运动障碍和新生儿癫痫脑病的患者进行测序。使用细胞检测和膜片钳记录来测试候选变体。

结果

WES 揭示了 基因中的一个纯合变异(p.Val368Leu),该变异涉及孔域中的保守残基,靠近钾离子选择性特征序列(TVGYG)。功能分析表明,突变蛋白在纯合状态下单独无法产生功能性通道,而与野生型共表达对 K 电流没有影响,与单独的野生型蛋白相似。奥卡西平(一种钠离子通道阻滞剂)的治疗对控制癫痫发作有效。

结论

这个新发现的变异是首次报道在 基因中以隐性遗传模式起作用。这些发现为通道病的诊断敲响了警钟,对于感兴趣的变异,未报告的表型表现或遗传模式可能会阻碍致病变异的识别和适当的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2077/7029237/51a277e17d96/jmedgenet-2019-106373f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2077/7029237/b1961a023557/jmedgenet-2019-106373f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2077/7029237/51a277e17d96/jmedgenet-2019-106373f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2077/7029237/b1961a023557/jmedgenet-2019-106373f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2077/7029237/51a277e17d96/jmedgenet-2019-106373f02.jpg

相似文献

1
Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia.KCNA1 活性完全丧失导致新生儿癫痫性脑病和运动障碍。
J Med Genet. 2020 Feb;57(2):132-137. doi: 10.1136/jmedgenet-2019-106373. Epub 2019 Oct 5.
2
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia.Kv1.1 通道 PVP 基序中新发变异与癫痫、发育迟缓伴共济失调的临床和功能研究。
Int J Mol Sci. 2022 Jul 22;23(15):8079. doi: 10.3390/ijms23158079.
3
De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.在 PVP 基序中发现的 KCNA1 新变异体导致婴儿癫痫性脑病和认知障碍,与反复出现的 KCNA2 变异体相似。
Am J Med Genet A. 2018 Aug;176(8):1748-1752. doi: 10.1002/ajmg.a.38840. Epub 2018 Jul 28.
4
Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.KCNA1基因中的显性负性突变p.Arg324Thr损害发作性共济失调中的Kv1.1通道功能。
Mov Disord. 2016 Nov;31(11):1743-1748. doi: 10.1002/mds.26737. Epub 2016 Aug 1.
5
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.一位阵发性共济失调、肌束震颤、痛性痉挛和代谢功能障碍患者的 KCNA1 基因突变。
Mol Cell Neurosci. 2017 Sep;83:6-12. doi: 10.1016/j.mcn.2017.06.006. Epub 2017 Jun 28.
6
Two novel KCNA1 variants identified in two unrelated Chinese families affected by episodic ataxia type 1 and neurodevelopmental disorders.在两个无关联的中国家庭中发现的两个新型 KCNA1 变体,受发作性共济失调 1 型和神经发育障碍的影响。
Mol Genet Genomic Med. 2020 Oct;8(10):e1434. doi: 10.1002/mgg3.1434. Epub 2020 Jul 23.
7
Both gain- and loss-of-function variants of KCNA1 are associated with paroxysmal kinesigenic dyskinesia.KCNA1 的获得性功能和丧失性功能变异均与发作性运动诱发性运动障碍有关。
J Genet Genomics. 2024 Aug;51(8):801-810. doi: 10.1016/j.jgg.2024.03.013. Epub 2024 Apr 2.
8
Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.Kcna1 突变型大鼠主要表现为肌纤维震颤、神经肌强直和自发性癫痫发作。
Brain Res. 2012 Jan 30;1435:154-66. doi: 10.1016/j.brainres.2011.11.023. Epub 2011 Nov 13.
9
Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.与KCNA1突变相关的临床异质性包括猝倒和无共济失调表现。
Neurogenetics. 2016 Jan;17(1):11-6. doi: 10.1007/s10048-015-0460-2. Epub 2015 Sep 22.
10
Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine.由甘氨酸构建的同工型选择性 KCNA1 钾通道开放剂。
J Pharmacol Exp Ther. 2020 Jun;373(3):391-401. doi: 10.1124/jpet.119.264507. Epub 2020 Mar 26.

引用本文的文献

1
Association of Voltage-Gated Potassium Channel Polymorphisms with the Risk and Prognosis of Epilepsy in the Saudi Population: A Case-Control Study.沙特人群中电压门控钾通道多态性与癫痫风险及预后的关联:一项病例对照研究
Medicina (Kaunas). 2025 Feb 25;61(3):396. doi: 10.3390/medicina61030396.
2
In vitro human ion channel assays predictive of drug-induced seizure.预测药物性癫痫发作的体外人离子通道试验
Toxicol Sci. 2025 Feb 1;203(2):253-268. doi: 10.1093/toxsci/kfae148.
3
Developmental and epileptic encephalopathies.发育性和癫痫性脑病。

本文引用的文献

1
Identification of a New Mutation Underlying Regressive Episodic Ataxia Type I.I型进行性发作性共济失调潜在新突变的鉴定
Front Neurol. 2018 Jul 25;9:587. doi: 10.3389/fneur.2018.00587. eCollection 2018.
2
De novo KCNA1 variants in the PVP motif cause infantile epileptic encephalopathy and cognitive impairment similar to recurrent KCNA2 variants.在 PVP 基序中发现的 KCNA1 新变异体导致婴儿癫痫性脑病和认知障碍,与反复出现的 KCNA2 变异体相似。
Am J Med Genet A. 2018 Aug;176(8):1748-1752. doi: 10.1002/ajmg.a.38840. Epub 2018 Jul 28.
3
Familial paroxysmal kinesigenic dyskinesia is associated with mutations in the KCNA1 gene.
Nat Rev Dis Primers. 2024 Sep 5;10(1):61. doi: 10.1038/s41572-024-00546-6.
4
Unusual Voltage-Gated Sodium and Potassium Channelopathies Related to Epilepsy.与癫痫相关的罕见电压门控钠通道和钾通道病
J Clin Neurol. 2024 Jul;20(4):402-411. doi: 10.3988/jcn.2023.0435.
5
Potassium channel-related epilepsy: Pathogenesis and clinical features.钾离子通道相关性癫痫:发病机制与临床特征。
Epilepsia Open. 2024 Jun;9(3):891-905. doi: 10.1002/epi4.12934. Epub 2024 Apr 1.
6
KCNA1 promotes the growth and invasion of glioblastoma cells through ferroptosis inhibition via upregulating SLC7A11.KCNA1通过上调SLC7A11抑制铁死亡,从而促进胶质母细胞瘤细胞的生长和侵袭。
Cancer Cell Int. 2024 Jan 3;24(1):7. doi: 10.1186/s12935-023-03199-9.
7
Genetic Background of Epilepsy and Antiepileptic Treatments.癫痫的遗传背景和抗癫痫治疗。
Int J Mol Sci. 2023 Nov 14;24(22):16280. doi: 10.3390/ijms242216280.
8
ClinPrior: an algorithm for diagnosis and novel gene discovery by network-based prioritization.ClinPrior:一种基于网络优先级排序的诊断和新基因发现算法。
Genome Med. 2023 Sep 7;15(1):68. doi: 10.1186/s13073-023-01214-2.
9
Genome-wide association study identified six loci associated with adverse drug reactions to aripiprazole in schizophrenia patients.全基因组关联研究确定了六个与精神分裂症患者对阿立哌唑药物不良反应相关的基因座。
Schizophrenia (Heidelb). 2023 Jul 25;9(1):44. doi: 10.1038/s41537-023-00369-6.
10
Novel Genetic Variants Expand the Functional, Molecular, and Pathological Diversity of Channelopathy.新型遗传变异扩大了通道病的功能、分子和病理多样性。
Int J Mol Sci. 2023 May 16;24(10):8826. doi: 10.3390/ijms24108826.
家族性发作性运动诱发性运动障碍与 KCNA1 基因突变有关。
Hum Mol Genet. 2018 Feb 15;27(4):625-637. doi: 10.1093/hmg/ddx430.
4
Dexamethasone-induced upregulation of Ca3.2 T-type Ca channels in rat cardiac myocytes.地塞米松诱导大鼠心肌细胞 Ca3.2 T 型钙通道的上调。
J Steroid Biochem Mol Biol. 2018 Apr;178:193-202. doi: 10.1016/j.jsbmb.2017.12.013. Epub 2017 Dec 17.
5
Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.KCNA2 相关性脑病的临床谱及基因型-表型相关性。
Brain. 2017 Sep 1;140(9):2337-2354. doi: 10.1093/brain/awx184.
6
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions.一位阵发性共济失调、肌束震颤、痛性痉挛和代谢功能障碍患者的 KCNA1 基因突变。
Mol Cell Neurosci. 2017 Sep;83:6-12. doi: 10.1016/j.mcn.2017.06.006. Epub 2017 Jun 28.
7
Diagnostic Targeted Resequencing in 349 Patients with Drug-Resistant Pediatric Epilepsies Identifies Causative Mutations in 30 Different Genes.对349例耐药性小儿癫痫患者进行诊断性靶向重测序,在30个不同基因中发现了致病突变。
Hum Mutat. 2017 Feb;38(2):216-225. doi: 10.1002/humu.23149. Epub 2016 Dec 9.
8
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
9
Dominant-negative mutation p.Arg324Thr in KCNA1 impairs Kv1.1 channel function in episodic ataxia.KCNA1基因中的显性负性突变p.Arg324Thr损害发作性共济失调中的Kv1.1通道功能。
Mov Disord. 2016 Nov;31(11):1743-1748. doi: 10.1002/mds.26737. Epub 2016 Aug 1.
10
A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.一个患有发作性共济失调和恶性高热的家族中的一种新型KCNA1突变。
Neurogenetics. 2016 Oct;17(4):245-249. doi: 10.1007/s10048-016-0486-0. Epub 2016 Jun 8.